Novel integrating adenoviral/retroviral hybrid vector for gene therapy.
A hybrid adenoviral vector system was designed to incorporate an excisable retroviral cassette that can be stably integrated into the host cell genome. The vector contains the terminal sequences of two Moloney murine leukemia virus retroviral long terminal repeats (LTRs), fused to form a junction fragment, and is flanked by two loxP recognition sequences. Cre recombinase-directed excision liberates a circular, double-stranded DNA molecule containing the LTR junction fragment. Despite the natural intermediate for retroviral integrase being a linear DNA molecule, we show that, in the presence of Cre and retroviral Gag and Pol, the excised circle can be integrated into the target cell genome through both specific integrase (Int)-directed mechanisms and by a random integration process. The loxP cassette, carrying in addition a selectable marker gene, was incorporated into the E1-deleted region of an adenoviral vector. Infection of cells expressing Cre, Gag, and Pol generated clones that survived long term in drug selection (>3 months). Int-mediated integration was demonstrated in seven of nine clones by sequencing of the integration sites. In addition, the introduction of the loxP cassette into 293 cells coexpressing Cre and Int alone in the absence of other Gag and Pol proteins was sufficient to catalyze the integration mechanism. These experiments demonstrate that it is possible to generate high-titer adenovirus-mediated delivery of a C-type retroviral provirus that can subsequently undergo retroviral Int-mediated integration into dividing and nondividing cells.
Murphy
Stephen J
SJ
Molecular Medicine Program, Guggenheim 1836, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA.
Chong
Heung
H
Bell
Stephen
S
Diaz
Rosa Maria
RM
Vile
Richard G
RG
D000260:Adenoviruses, Human / Q000235:genetics*; D020029:Base Pairing; D001665:Binding Sites; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics*; D006801:Humans; D019426:Integrases; D008979:Moloney murine leukemia virus / Q000235:genetics*; D010957:Plasmids; D011533:Proviruses; D011995:Recombination, Genetic; D020079:Terminal Repeat Sequences; D014407:Tumor Cells, Cultured; D014764:Viral Proteins; D016662:Virus Integration
D014764:Viral Proteins; C045073:Cre recombinase; D019426:Integrases